Research antibiotic resistance and rate of bacteria cause urinary tract infections in patients placed urinary catheter

  • Thuc Nguyen Tri Military Central Hospital 108
  • Manh Nguyen Dang Military Central Hospital 108

Main Article Content

Keywords

Urinary tract infections (UTI), antimicrobial resistance, urinary catheter

Abstract

Objective: To study the pathogenic bacteria in urinary tract infections in patients with urinary catheters and evaluated their antibiotic resistance at 108 Military Central Hospital. Subject and method: Descriptive study, 183 urine specimens of patients with urinary tract infections due to urinary catheterization. Result and conclusion: The incidence of E. coli was highest at 41.53%, followed by K. pneumoniae at more than 15%, Pseudomonas aeruginosa were 10.38% and Acinetobacter baumannii were 4.37%. The third and fourth generation cephalosporins resistance rates of E. coli ranged from 40% to 61.5%. We had not seen resistance to carbapenems. K. pneumoniae had a high rate of resistance to quinolone and third generation cephalosporins, the prevalence of resistance to imipenem was 9.4% and meropenem was 6.5%. Pseudomonas aeruginosa had a very high rate of resistance to most antibiotics, resistance to cefepime and amikacin were 36.7% and 22.7%. The resistance rate of Acinetobacter baumannii with imipenem was 40%, meropenem was 39.1% and colistin was 0.0%.


 

Article Details

References

1. Trần Thị Thanh Nga (2011) Nhiễm khuẩn và đề kháng kháng sinh tại Bệnh viện Chợ Rẫy năm 2008 - 2009. Tạp chí Y học thành phố Hồ Chí Minh, tập 15, phụ bản số 4, tr. 545-549.
2. Clinical and laboratory standards institute (2008) Performance standards for antimicrobial disk susceptibility tests. M100-S18, Wayne, P.A, USA, 28(1): 113.
3. Paterson DL et al (2004) Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum b-lactamases. Clinical Infectious Diseases 39: 31-37.
4. Paterson DL and Bonomo (2005) RA-extended-spectrum beta-lactamases: A clinical update. American Society for Microbiology 18(4): 657-686.
5. Pankuch GA (2008) Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrobial agents and chemotherapy, Jan: 333-336.